盆腔放疗后人工尿道括约肌植入的时机考量
本研究为双机构回顾性研究,纳入2011年1月1日至2023年7月1日期间在盆腔放疗后首次(初次)植入人工尿道括约肌的72例患者,比较放疗后2、3、4、5年内与超过上述时间植入者的装置修正/取出风险。结果显示各时间点早期与晚期植入的装置修正/取出风险均无显著差异(P值分别为.3、.3、.4、.4);植入越晚,因感染/侵蚀而修正/取出的比例呈持续升高趋势(R2=0.98)。作者认为,尽管样本量小,放疗后5年内植入人工尿道括约肌的装置寿命相当,但较晚植入可能因侵蚀/感染而有更高的取出率。
要点
- 放疗后2、3、4、5年内与超过上述时间植入,装置修正/取出风险均无显著差异(P=.3、.3、.4、.4)。
- 中位随访57.5个月,36例(50%)装置修正/取出,机械故障14例(19.4%)、装置侵蚀12例(16.7%)。
- 植入越晚,因感染/侵蚀而修正/取出的比例呈持续升高趋势(R2=0.98)。
核心结论
- 尽管样本量小,本研究提示放疗后5年内植入人工尿道括约肌的装置寿命相当;但较晚植入可能因侵蚀/感染而有更高的取出率。
研究设计与样本
- 双机构回顾性研究,纳入2011年1月1日至2023年7月1日期间盆腔放疗后首次(初次)植入人工尿道括约肌的患者72例,中位年龄65.5岁(四分位距70-81.25)。
- 采用Kaplan-Meier曲线比较放疗后每一年(早于/晚于2、3、4、5年)植入的装置修正/取出风险比,并以Pearson相关系数分析修正/取出原因(侵蚀/感染与其他)的趋势。
主要发现
- 15例(20.8%)既往接受过一种或多种尿道或膀胱颈干预:尿道成形术1例(1.4%)、内尿道切开术7例(9.7%)、膀胱颈切开术9例(12.5%)。
- 中位随访57.5个月(四分位距13-107),共36例(50%)装置修正/取出,主要原因为机械故障14例(19.4%)和装置侵蚀12例(16.7%)。
- 放疗后早于与晚于2、3、4、5年植入的装置修正/取出风险均无显著差异,P值分别为.3、.3、.4、.4。
- 植入越晚,因感染/侵蚀而修正/取出的比例呈持续升高趋势:R2=0.98。
局限性
- 原文自述样本量小(small sample size)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To explore the optimal timing for placing an artificial urinary sphincter (AUS) postradiation therapy (RT). METHODS: A bi-institutional retrospective review of all patients who underwent their first (virgin) AUS placement after pelvic RT between January 1, 2011 and July 1, 2023. To determine the optimal timeline for device implantation 2-5years post-RT, we compared hazard ratios for device revision/explantation (Rev/Exp) using Kaplan-Meier curves for each year (earlier vs later than 2/3/4/5 years post-RT). The Pearson correlation coefficient identified trends in Rev/Exp reasons (erosion/infection vs other). RESULTS: Seventy-two patients met our inclusion criteria with a median age of 65.5years (interquartile range 70-81.25). Fifteen (20.8%) had undergone one or more previous urethral or bladder neck interventions (urethroplasty in 1 [1.4%], internal urethrotomy in 7 [9.7%], and bladder neck incision in 9 [12.5%]). After a median follow-up of 57.5months (interquartile range 13-107), a total of 36 (50%) devices were Rev/Exp, with mechanical failure in 14 (19.4%) and device erosion in 12 (16.7%) being the main reasons. Device survival analysis revealed no significant difference in the risk of device Rev/Exp when implanted earlier vs later than 2, 3, 4, or 5years post-RT, with P-values of .3, .3, .4, and .4, respectively. A constant trend toward higher infection/erosion rates as indication for device Rev/Exp the later the insertion was noticed: R2 = 0.98. CONCLUSION: Despite a small sample size, our study indicates that implanting an AUS within 5 years after RT shows comparable device lifespan. However, later insertions may have higher removal rates due to erosion/infection. CLINICAL TRIAL REGISTRATION: Not applicable.
引用
- Malshy K, Marthi S, Ortiz R, et al. Timing Considerations for Artificial Urinary Sphincter Implantation Postpelvic Radiotherapy. Urology. 2024. PMID: 39089495. doi:10.1016/j.urology.2024.07.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。